7don MSN
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
1d
News Medical on MSNMedtronic receives FDA approval for BrainSense Adaptive DBS technologyFor the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
The brain-computer interface technology personalizes therapy based on an individual’s brain activity.
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
Medtronic said Monday the U.S. Food and Drug Administration has approved a brain-stimulation device as a treatment for people with Parkinson's disease, a major milestone for the technology.
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
Medtronic has enhanced its Percept DBS neurostimulators with BrainSense Adaptive technology, introducing aDBS for people living with Parkinson’s. It provides enhanced therapy personalization for ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results